RxDoctor Payments Data

John Graham

Cardiovascular Disease · Indianapolis, INNPI 1669443198

Payments from drug & device makers

$1,445in general payments, 2019–2025

Across 118 payments — averaging $12.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$371
  • Novartis$203
  • AstraZeneca$177
  • Merz North America, Inc.$160
  • Pfizer$136
  • Boston Scientific$97
  • plus $299 from 10 others

What the payments were for

  • Food & beverage$1,43499%
  • Education$101%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,445 in reported general payments places this provider in the 35th percentile of 408 cardiovascular disease providers in Indiana.

See all cardiovascular disease providers in Indiana

Other cardiovascular disease in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →